Dimethyl fumarate versus interferon for treatment of relapsing-remitting multiple Sclerosis

被引：0
|
作者：
Sattarnezhad, Neda [1 ]
Healy, Brian C. [1 ,2 ]
Baharnoori, Moogeh [1 ]
Diaz-Cruz, Camilo [1 ]
Stankiewicz, James [1 ]
Weiner, Howard L. [1 ]
Chitnis, Tanuja [1 ,3 ]
机构：
[1] Brigham & Womens Hosp, Partners MS Ctr, Boston, MA 02115 USA
[2] MGH Biostat Ctr, Boston, MA USA
[3] Massachusetts Gen Hosp, Pediat MS Ctr, Boston, MA 02114 USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.381
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
    Bomprezzi, Roberto
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (01) : 20 - 30
  • [2] Successful treatment with dimethyl fumarate in a child with relapsing-remitting multiple sclerosis
    Saijo, Naoya
    Abe, Yu
    Oikawa, Yoshitsugu
    Okubo, Yukimune
    Endo, Wakaba
    Numata-Uematsu, Yurika
    Takahashi, Toshiyuki
    Uematsu, Mitsugu
    [J]. BRAIN & DEVELOPMENT, 2022, 44 (05): : 353 - 356
  • [3] Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Nehzat, Nasim
    Mirmosayyeb, Omid
    Barzegar, Mahdi
    Vosoughi, Reza
    Fazeli, Erfane
    Shaygannejad, Vahid
    [J]. NEUROLOGY RESEARCH INTERNATIONAL, 2021, 2021
  • [4] Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis
    Boullosa-Lale, Silvia
    Gonzalez-Freire, Lara
    Martinez-Martinez, Luciano
    Crespo-Diz, Carlos
    [J]. FARMACIA HOSPITALARIA, 2021, 45 (02) : 73 - 76
  • [5] Early versus delayed initiation of fingolimod or dimethyl fumarate in relapsing-remitting multiple sclerosis
    Lorscheider, J.
    Schadelin, S.
    Benkert, P.
    Lienert, C.
    Hanni, P.
    Derfuss, T.
    Decard, B.
    Kuhle, J.
    Kappos, L.
    Yaldizli, O.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 257 - 258
  • [6] Dimethyl fumarate: A guide to its use in relapsing-remitting multiple sclerosis
    Keating G.M.
    Burness C.B.
    Deeks E.D.
    [J]. Drugs & Therapy Perspectives, 2014, 30 (9) : 303 - 308
  • [7] Real world experience with dimethyl fumarate in relapsing-remitting multiple sclerosis
    Cox, S. R.
    Jordan, S.
    Sharma, D.
    O'Boyle, G.
    Tubridy, N.
    Hutchinson, M.
    Mcguigan, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 614 - 615
  • [8] EXTENDING THERAPEUTIC POSSIBILITIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: DIMETHYL FUMARATE
    Matolcsi Judit
    Rozsa Csilla
    [J]. IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (1-2): : 7 - 14
  • [9] Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis
    Muller, Jannis
    Schadelin, Sabine
    Lorscheider, Johannes
    Benkert, Pascal
    Hanni, Peter
    Schmid, Jurg
    Kuhle, Jens
    Derfuss, Tobias
    Granziera, Cristina
    Yaldizli, Ozgur
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3809 - 3818
  • [10] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
12345